Inhibition of SHP2 has recently been shown to ameliorate the responsiveness of synovial fibroblast-like cells from patients with rheumatoid arthritis that exhibit a characteristic inflammatory and invasive phenotype to tumor necrosis factor and PDGF21,22. Here, TNF is linked to rheumatoid arthritis.